# G+FLAS Life Sciences, Inc.: Research, Seoul, South Korea

> G+FLAS Life Sciences, Inc.: G+FLAS Life sciences has been developing CRISPR/Cas foundation technologies as well as innovative applications for better human...

Source: https://millionrounds.com/startup/g-flas-life-sciences-inc (Millionrounds; every figure on the page links to its filing or article)

South Korea · [Research startup](https://millionrounds.com/companies)

# G+FLAS Life Sciences, Inc.

G+FLAS Life sciences has been developing CRISPR/Cas foundation technologies as well as innovative applications for better human health, including gene therapy drugs, biopharmaceuti

Funding reported Last round: Series E

Research Seoul, South Korea

Company summary

- **Founded:** 2014 12 years old
- **Team:** 8 1 to 10 people
- **Funding reported:** 37.9B as listed, currency not stated
- **Last round:** Series E Jun 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for G+FLAS Life Sciences, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About G+FLAS Life Sciences, Inc.

G+FLAS Life sciences has been developing CRISPR/Cas foundation technologies as well as innovative applications for better human health, including gene therapy drugs, biopharmaceuti

cals, and novel seeds with desired traits.

## What company datasets say G+FLAS Life Sciences, Inc. raised

Funding, as reported

Reported in all **37.9B** in the source's currency

Rounds **6**

Last round **Series E**

Last round size **2.5M**

Last round date **Jun 2022**

Investors listed **13**

## On 2 portfolio pages

Investors who name them

- [MiraKle Lab](https://millionrounds.com/fund/mirakle-lab)
- [ActnerLab](https://millionrounds.com/fund/actnerlab)

Each firm lists G+FLAS Life Sciences, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

crispr-casn health care crispr mechanisms biotechnology research distribution manufacturing crispr products crispr applications gmp manufacturing dnafree genome editing crispr non-gmo non-gmo editing gfcas12a genome editing hospital & health care crispr enzyme

Built with from their website

Google Tag Manager NAVER OpenSSL Apache YouTube CloudFlare Viewport Meta CentOS Microsoft Exchange Microsoft 365 Apps & Services

+8 more

Mobile Friendly Open Graph jQuery EditPlus Google Analytics Naver Analytics GoDaddy Domains Microsoft Exchange Online

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 8731
- **Region:** Seoul
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/g-flas-life-sciences)

## Research in South Korea

Startups like it

- [**Galux** founded 2020 *Raised*](https://millionrounds.com/company/galux)
- [**ExoCoBio** founded 2017 *Raised*](https://millionrounds.com/company/exocobio)
- [**iN Therapeutics** Yongin-si · founded 2020](https://millionrounds.com/startup/in-therapeutics)
- [**Mitoimmune Therapeutics Inc.** Seoul · founded 2018](https://millionrounds.com/startup/mitoimmune-therapeutics-inc)
- [**Cyrus Therapeutics** founded 2019](https://millionrounds.com/startup/cyrus-therapeutics)
- [**Dx & Vx** founded 2001](https://millionrounds.com/startup/dx-vx)
- [**Cellmeat** Seoul · founded 2019](https://millionrounds.com/startup/cellmeat)
- [**Bertis Inc** Seongnam-si · founded 2014](https://millionrounds.com/startup/bertis-inc)

## Is this your company?

Add your raise, your deck and your story, and put G+FLAS Life Sciences, Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)